Cargando…
TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12
Breast cancer (BC) is among the most common malignant diseases and metastasis is the handcuff of treatment. Cancer metastasis is a multistep process associated with the epithelial-mesenchymal transition (EMT) program. Several studies have demonstrated that transcriptional repressor GATA binding 1 (T...
Autores principales: | Hu, Jing, Su, Peng, Jiao, Meng, Bai, Xinnuo, Qi, Mei, Liu, Hui, Wu, Zhen, Sun, Jingtian, Zhou, Gengyin, Han, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884189/ https://www.ncbi.nlm.nih.gov/pubmed/29471243 http://dx.doi.org/10.1016/j.tranon.2018.01.009 |
Ejemplares similares
-
Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer
por: Su, Peng, et al.
Publicado: (2014) -
TRPS1 Confers Multidrug Resistance of Breast Cancer Cells by Regulating BCRP Expression
por: Hu, Jing, et al.
Publicado: (2020) -
Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms
por: Brecqueville, M, et al.
Publicado: (2011) -
Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats
por: XIAO, XIAOYAN, et al.
Publicado: (2015) -
Trps1 Regulates Biliary Epithelial-Mesenchymal Transition and Has Roles during Biliary Fibrosis in Liver Grafts: A Preliminary Study
por: Zhe, Cheng, et al.
Publicado: (2015)